{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:12:56Z","timestamp":1789935176980,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009015","name":"Abbott Japan Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cyto.2026.157128","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T21:57:24Z","timestamp":1771883844000},"page":"157128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Transition of serum-free IL-18 levels in systemic juvenile idiopathic arthritis measured by a novel detection method"],"prefix":"10.1016","volume":"201","author":[{"given":"Yuki","family":"Miwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azusa","family":"Haba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuka","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji O.","family":"Kamatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6552","key":"10.1016\/j.cyto.2026.157128_bb0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cyto.2026.157128_bb0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41584-023-01053-w","article-title":"Biological and clinical roles of IL-18 in inflammatory diseases","volume":"20","author":"Landy","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2026.157128_bb0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cyto.2026.157128_bb0020","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","article-title":"Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset still\u2019s disease","volume":"44","author":"Kawashima","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.cyto.2026.157128_bb0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/cyto.2001.0914","article-title":"A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18","volume":"14","author":"Novick","year":"2001","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.cyto.2026.157128_bb0035","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","article-title":"Elevated serum levels of free interleukin-18 in adult-onset still\u2019s disease","volume":"55","author":"Girard","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.cyto.2026.157128_bb0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/art.41976","article-title":"Excess serum Interleukin-18 distinguishes patients with pathogenic mutations in PSTPIP1","volume":"74","author":"Stone","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"20","key":"10.1016\/j.cyto.2026.157128_bb0045","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1182\/bloodadvances.2023010708","article-title":"Free interleukin-18 is elevated in CD22 CAR T-cell-associated hemophagocytic lymphohistiocytosis-like toxicities","volume":"7","author":"Rocco","year":"2023","journal-title":"Blood Adv."},{"issue":"11","key":"10.1016\/j.cyto.2026.157128_bb0050","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/cb3002478","article-title":"Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate","volume":"7","author":"Hall","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.cyto.2026.157128_bb0055","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1073\/pnas.97.3.1190","article-title":"Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18","volume":"97","author":"Kim","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.cyto.2026.157128_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038423","article-title":"TRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88","volume":"7","author":"Ohnishi","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cyto.2026.157128_bb0065","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis- second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.cyto.2026.157128_bb0070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3899\/jrheum.180168","article-title":"Toward new classification criteria for juvenile idiopathic arthritis: first steps, pediatric rheumatology international trials organization international consensus","volume":"46","author":"Martini","year":"2019","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.cyto.2026.157128_bb0075","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/acr.20497","article-title":"American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis","volume":"63","author":"Wallace","year":"2011","journal-title":"Arthritis Care Res."},{"issue":"3","key":"10.1016\/j.cyto.2026.157128_bb0080","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2026.157128_bib181","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1074-7613(00)80013-8","article-title":"Interleukin-18 binding protein; a novel modulator of the Th1 cytokine response","volume":"10","author":"Novick","year":"1999","journal-title":"Immunity"},{"issue":"24","key":"10.1016\/j.cyto.2026.157128_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413505","article-title":"IL-18 and IL-18BP: a unique dyad in health and disease","volume":"25","author":"Novick","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2026.157128_bb0090","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1038\/ncomms6340","article-title":"The structural basis for receptor recognition of human interleukin-18","volume":"5","author":"Tsutsumi","year":"2014","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.cyto.2026.157128_bb0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2332\/allergolint.O-08-546","article-title":"Expression, purification and structural analysis of human IL-18 binding protein: a potent therapeutic molecule for allergy","volume":"57","author":"Kimura","year":"2008","journal-title":"Allergol. Int."},{"key":"10.1016\/j.cyto.2026.157128_bb0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-0716-3331-1_21","article-title":"Detection of free bioactive IL-18 and IL-18BP in inflammatory disorders","volume":"2691","author":"Fauteux-Daniel","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.cyto.2026.157128_bb0105","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/art.42037","article-title":"2021 American College of Rheumatology guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis","volume":"74","author":"Onel","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.cyto.2026.157128_bb0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acr.23277","article-title":"Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis","volume":"70","author":"Schulert","year":"2018","journal-title":"Arthritis Care Res."},{"issue":"2","key":"10.1016\/j.cyto.2026.157128_bb0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cyto.2012.02.006","article-title":"Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6","volume":"58","author":"Shimizu","year":"2012","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.cyto.2026.157128_bb0120","first-page":"823","article-title":"Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis","volume":"34","author":"Lotito","year":"2007","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.cyto.2026.157128_bb0125","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/ard-2024-225851","article-title":"EULAR\/PReS recommendations for the diagnosis and management of still\u2019s disease, comprising systemic juvenile idiopathic arthritis and adult-onset still\u2019s disease","volume":"83","author":"Fautrel","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.cyto.2026.157128_bb0130","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaci.2023.05.027","article-title":"Distinct roles of IL-18 and IL-1beta in murine model of macrophage activation syndrome","volume":"152","author":"Mizuta","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2026.157128_bb0135","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Girard-Guyonvarc\u2019h","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2026.157128_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155781","article-title":"Balance between Interleukin-18 and Interleukin-18 binding protein in auto-inflammatory diseases","volume":"150","author":"Harel","year":"2022","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cyto.2026.157128_bb0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/rheumatology\/kez282","article-title":"IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome","volume":"59","author":"Yasin","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.cyto.2026.157128_bb0150","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.cyto.2026.157128_bb0155","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cyto.2012.11.025","article-title":"Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles","volume":"61","author":"Shimizu","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2026.157128_bb0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","article-title":"Cytokine profile in adult-onset still\u2019s disease: comparison with systemic juvenile idiopathic arthritis","volume":"169","author":"Inoue","year":"2016","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2026.157128_bb0165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clim.2015.06.005","article-title":"Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"160","author":"Shimizu","year":"2015","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2026.157128_bb0170","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/art.24750","article-title":"Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"de Jager","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.cyto.2026.157128_bb0175","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/keu524","article-title":"Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-gamma","volume":"54","author":"Put","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2026.157128_bb0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cyto.2019.03.018","article-title":"Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome","volume":"119","author":"Mizuta","year":"2019","journal-title":"Cytokine"}],"updated-by":[{"DOI":"10.1016\/j.cyto.2026.157201","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000}},{"DOI":"10.1016\/j.cyto.2026.157201","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:56:20Z","timestamp":1789934180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466626000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"alternative-id":["S1043466626000232"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157128","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transition of serum-free IL-18 levels in systemic juvenile idiopathic arthritis measured by a novel detection method","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157128"}}